Travere Therapeutics, Inc. · NASDAQ:TVTX

Rote William E. sold 209,048 Travere Therapeutics, Inc. shares (Form 4)

Traded Sep 15 to Sep 16, 2026 · Filed Sep 17, 2026

From Sep 15 to Sep 16, 2026, Rote William E. (Chief Research Officer) sold 209,048 Travere Therapeutics, Inc. shares at an average US$62.83 for US$13.1M under a trading plan, leaving 98,197 shares. Filed Sep 17, 2026 (Form 4).

Sold
209,048 shares
Price
US$62.83 average (US$61.99 to US$65.31)
Value
US$13.1M
Holding after
98,197 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Research Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockOption exercise39,000US$25.25154,745Direct
Sep 15, 2026Common StockOption exercise39,650US$17.96194,395Direct
Sep 15, 2026Common StockSale63,907US$61.99130,488Direct
Sep 15, 2026Common StockSale29,021US$62.66101,467Direct
Sep 15, 2026Common StockSale3,000US$63.6598,467Direct
Sep 15, 2026Common StockSale270US$65.3198,197Direct
Sep 16, 2026Common StockOption exercise350US$17.9698,547Direct
Sep 16, 2026Common StockOption exercise55,000US$15.46153,547Direct
Sep 16, 2026Common StockOption exercise57,500US$26.88211,047Direct
Sep 16, 2026Common StockSale65,104US$63.12145,943Direct
Sep 16, 2026Common StockSale47,746US$63.6198,197Direct

Source

View original at SEC

Related